Steven N. Perrin
President at ELEDON PHARMACEUTICALS, INC.
Net worth: 2 060 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Fernando G. Vieira | M | - |
ALS Therapy Development Foundation, Inc.
 ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 23 years |
| Bryan E. Smith | M | 45 | 3 years | |
| James Allen Heywood | M | 58 |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 25 years |
| Theodore Reich | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 17 years |
| Jan Hillson | M | 71 | 3 years | |
| Carol Hamilton | F | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 19 years |
| Bashar Al-Nakhala | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 19 years |
| John S. McBride | M | 72 | 7 years | |
| June Lee | M | 58 | 4 years | |
| David-Alexandre C. Gros | M | 51 | 4 years | |
| Susan Alexander | F | 67 | 21 years | |
| Walter C. Ogier | M | 67 | 4 years | |
| Paul Little | M | 60 | 3 years | |
| Allan Kirk | M | - | 1 years | |
| Keith Katkin | M | 52 | 7 years | |
| Andrew Niblock | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| James Robinson | M | 54 | 1 years | |
| Lynne Nieto | F | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| Kent Bransford | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| David Hovland | M | - | 3 years | |
| Jennifer Gore Dwyer | F | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 11 years |
| Robert Sepucha | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 11 years |
| John Herberger | M | - | 2 years | |
| Julie Swan | F | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 12 years |
| Alexander Cappello | M | 68 |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| Alan Gill | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 17 years |
| Michael Marion Smith | M | 69 |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 11 years |
| Steve Fowler | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| John Heywood | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| Charles D. Ferris | M | 90 |
Boston College
| 38 years |
| Keith P. Melanson | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| Spiros Jamas | M | 63 |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| Augustine L. Nieto | M | 66 |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 17 years |
| Ken Thompson | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 24 years |
| Robert Rodin | M | 70 |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 18 years |
| Stanley H. Appel | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| Paul A. Sallaberry | M | 68 |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | - |
| Leslie Michelson | M | 73 |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 20 years |
| Eliezer Katz | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jon S. Kuwahara | M | 59 | 4 years | |
| William Rastetter | M | 75 | 19 years | |
| William Young | M | 79 | 11 years | |
| Sylvie Grégoire | M | 63 | 8 years | |
| Barbara McKenna | F | - |
Boston College
| 7 years |
| Samantha Truex | F | - | 8 years | |
| Robert Goldstein | M | - |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology ALS Therapy Development Foundation, Inc. develops therapeutic drugs. It provides unmet medical needs. The firm discovers small molecules, protein biologics, gene therapies, and cell-based constructs. The company was founded by James Allen Heywood in 1999 and is headquartered in Cambridge, MA. | 14 years |
| Gilmore O’Neill | M | 59 | 15 years | |
| Eric S. Hoffman | M | 54 | 5 years | |
| Robert A. Hamm | M | 72 | 7 years | |
| Brian A. Murphy | M | - |
Boston College
| 4 years |
| Francis Gannon | M | - |
Boston College
| 6 years |
| Maureen Bennett | F | - |
Boston College
| 7 years |
| Gary Lyons | M | 73 | 6 years | |
| Scott A. Gieselman | M | 60 |
Boston College
| 7 years |
| Craig Eric Schneier | M | 76 | 8 years | |
| Donald Readlinger | M | - |
Boston College
| 4 years |
| Gary Wing | M | - |
Boston College
| 2 years |
| Robin H. Rome | F | - |
Boston College
| 4 years |
| Timothy Cooney | M | 58 |
Boston College
| 4 years |
| David Dwyer | M | - |
Boston College
| 4 years |
| Catherine Vaczy | F | 62 |
Boston College
| 4 years |
| Pete Meyers | M | 55 |
Boston College
| 4 years |
| Michael F. Coyne | M | - |
Boston College
| 3 years |
| William R. Baldiga | M | - |
Boston College
| 3 years |
| Joseph Matarese | M | - |
Boston College
| 4 years |
| Amy Seigenthaler | F | - |
Boston College
| 4 years |
| Eva Selhub | M | 56 |
Boston University School of Medicine
| 3 years |
| Joe Callanan | M | - |
Boston College
| 4 years |
| Mauricio Samper | M | - |
Boston College
| 4 years |
| Richard Hampson | M | - |
Boston College
| 4 years |
| Jason Kelly | M | - |
Boston College
| 4 years |
| Jo Anne Ferullo | F | - |
Boston College
| 4 years |
| Andrew Fentress | M | 54 |
Boston College
| 4 years |
| Debra Wong Yang | F | - |
Boston College
| 3 years |
| Kenneth Robert Lamb | M | - |
Boston College
| 3 years |
| Michael P. Malloy | M | 64 |
Boston College
| 3 years |
| R. Scott Ervin | M | - |
Boston College
| 3 years |
| W. Heavey | M | - |
Boston College
| 4 years |
| Bettina Doulton | F | - |
Boston College
| 4 years |
| Robert Downs Cresci | M | - |
Boston College
| 4 years |
| James Didden | M | - |
Boston College
| 4 years |
| Rich Litchfield | M | - |
Boston College
| 4 years |
| Timothy Ernest Keefe | M | - |
Boston College
| 4 years |
| David Cobey | M | - |
Boston College
| 4 years |
| Ken Scott | M | 57 |
Boston College
| 4 years |
| Joseph C. McCready | M | - |
Boston College
| 4 years |
| James L. Bromley | M | - |
Boston College
| 4 years |
| Pierre Donahue | M | - |
Boston College
| 4 years |
| Jamie Patrick Linkowski | M | - |
Boston College
| 4 years |
| Mitchell S. Bloom | M | - |
Boston College
| 3 years |
| Nick Gendron | M | - |
Boston College
| 4 years |
| Jeremiah T. Doyle | M | - |
Boston College
| 4 years |
| Steven J. Musumeci | M | - |
Boston College
| 4 years |
| David E. Wezdenko | M | 60 |
Boston College
| 4 years |
| Chet M. Thompson | M | - |
Boston College
| 4 years |
| Ugo D. DeBlasi | M | 62 |
Boston College
| 4 years |
| Stephen T. Mears | M | - |
Boston College
| 4 years |
| Peter J. Klanian | M | - |
Boston College
| 4 years |
| Norm Page | M | - |
Boston College
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Steven N. Perrin
- Personal Network
